These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2138654)

  • 21. Fluconazole and amphotericin B antifungal therapies do not negate the protective effect of endogenous tumor necrosis factor in a murine model of fatal disseminated candidiasis.
    Louie A; Baltch AL; Smith RP; Franke MA; Ritz WJ; Singh JK; Gordon MA
    J Infect Dis; 1995 Feb; 171(2):406-15. PubMed ID: 7844378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis.
    Walsh TJ; Lee JW; Melcher GP; Navarro E; Bacher J; Callender D; Reed KD; Wu T; Lopez-Berestein G; Pizzo PA
    J Infect Dis; 1992 Jul; 166(1):121-33. PubMed ID: 1535092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
    Brockmeyer NH; Hantschke D; Olbricht T; Hengge UA; Goos M
    Mycoses; 1991; 34 Suppl 1():83-6. PubMed ID: 1818270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses.
    Kujath P; Lerch K; Kochendörfer P; Boos C
    Infection; 1993; 21(6):376-82. PubMed ID: 8132367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
    Sugar AM; Hitchcock CA; Troke PF; Picard M
    Antimicrob Agents Chemother; 1995 Mar; 39(3):598-601. PubMed ID: 7793858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungals in systemic neonatal candidiasis.
    Frattarelli DA; Reed MD; Giacoia GP; Aranda JV
    Drugs; 2004; 64(9):949-68. PubMed ID: 15101785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
    Thaler M; Bacher J; O'Leary T; Pizzo PA
    J Infect Dis; 1988 Jul; 158(1):80-8. PubMed ID: 3392423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Walsh TJ; Denning DW; Drusano GL
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3760-2. PubMed ID: 17682101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
    Graybill JR; Najvar LK; Holmberg JD; Luther MF
    Antimicrob Agents Chemother; 1995 Apr; 39(4):924-9. PubMed ID: 7785997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy in experimental invasive aspergillosis.
    George D; Kordick D; Miniter P; Patterson TF; Andriole VT
    J Infect Dis; 1993 Sep; 168(3):692-8. PubMed ID: 8354911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical microbiological case: chronic disseminated candidiasis unresponsive to treatment.
    Ratip S; Odabaşi Z; Karti S; Cetiner M; Yeğen C; Cerikcioğlu N; Bayik M; Korten V;
    Clin Microbiol Infect; 2002 Jul; 8(7):435-6, 442-4. PubMed ID: 12199855
    [No Abstract]   [Full Text] [Related]  

  • 33. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
    Barbaro G; Barbarini G; Di Lorenzo G
    Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
    J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful antifungal treatment of disseminated candidiasis associated with ARDS.
    Akiba Y; Osanai S; Nakano H; Matsumoto H; Onodera S
    Kansenshogaku Zasshi; 1993 Mar; 67(3):231-5. PubMed ID: 8486980
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.
    Petraitiene R; Petraitis V; Kelaher AM; Sarafandi AA; Mickiene D; Groll AH; Sein T; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2005 May; 49(5):2084-92. PubMed ID: 15855534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis.
    Witt MD; Bayer AS
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2481-5. PubMed ID: 1810181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of disseminated Torulopsis glabrata infection with DO870 and amphotericin B.
    Atkinson BA; Bocanegra R; Colombo AL; Graybill JR
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1604-7. PubMed ID: 7979293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
    Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
    Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
    Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA
    J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.